Pre-market Hot Trades in US Stocks

Outlook Therapeutics is up 8.84% in pre-market trading. Based on recent key news:

1. On July 25, Outlook Therapeutics announced that its drug Lytenava received approval from the US FDA for the treatment of wet age-related macular degeneration (AMD). This approval marks Outlook's first entry into the US market and validates its years of regulatory efforts. The stock price rose 18% as a result. Source: Reuters

2. On July 24, strong technical support trends were noted, but overbought signals increased short-term risks. Company events added upside potential from regulatory progress, but dilution concerns partially offset this impact. Source: Reuters

3. On July 24, Outlook Therapeutics expects Lytenava to be available to US patients by the end of the year and anticipates having 12 years of market exclusivity under BPCIA. Source: Reuters The ophthalmic market is becoming more competitive, with significant regulatory progress.

SAP is up 4.80% in pre-market trading. Based on recent key news:

1. On July 24, SAP released its second-quarter financial report, with cloud business revenue exceeding expectations, driving the stock price up. SAP's cloud revenue grew 24% year-over-year to €6.28 billion, indicating strong market demand. Source: Benzinga

2. On July 24, SAP announced it will focus on expanding cloud revenue and AI capabilities to enhance customer trust. This strategic plan has boosted market confidence in SAP's future growth. Source: Benzinga

3. On July 24, SAP Executive Board member Christian Kurt Klein purchased company stock, demonstrating confidence in the company's future development. Source: EQS News Strong growth in cloud business and focus on AI strategy are noteworthy.

Top Gainers in Pre-market US Stocks

Lion Group Holding is up 106.48% in pre-market trading. Based on recent key news:

1. On July 23, HRT Financial sold 34,989 shares of Lion Group Holding, reducing its holdings to 63,695 shares. This sale may have sparked market attention on the company's stock price, driving it up. Source: EDGAR

2. On July 24, Spark's AI analyst rated Lion Group Holding as neutral, mainly due to the company's poor financial performance, ongoing losses, unstable revenue, and increasing leverage. The technical outlook also appeared weak, with the stock price far below major moving averages and a negative MACD. Source: TipRanks

3. On July 24, the Geene 2.0 ecosystem absorbed the domestic leading AI interactive marketing company Zhizhi Intelligent as a core partner, promoting the integration of AI live streaming technology with Southeast Asian market resources, which may positively impact Lion Group Holding's market prospects Source: Yizhi Intelligent The overall market performance is weak, and capital flows are unstable.

Matinas BioPharma pre-market rose 66.94%. Based on recent key news:

1. On July 24, Matinas BioPharma announced the termination of its sales agreement with BTIG, effective immediately. The agreement allowed the company to sell up to $50 million of common stock in the market. BTIG terminated the agreement under contractual rights, with no termination fees or expenses. This change removes the market financing option unless Matinas establishes a new plan. Following this announcement, the stock price surged.

2. On July 24, after BTIG terminated the sales agreement, Matinas BioPharma incurred no termination fees or expenses. This move is seen as a positive signal regarding the company's financial condition, driving the stock price up.

3. On July 24, analyst Spark maintained a neutral stance on MTNB stock, primarily due to the company's very weak financial performance, with no revenue, ongoing losses, and cash burn. Although the technical outlook remains negative, the market reacted positively to the company's strategic changes and asset sales, leading to a rise in stock price. The market's positive reaction to the company's strategic changes drove the stock price up.

T3 Defense pre-market rose 42.76%. Based on recent key news:

1. On July 24, T3 Defense submitted SEC filings showing its strategic acquisition plan. The company focuses on acquiring and improving operational businesses, planning to expand strategic holdings through follow-up transactions and close collaboration with management. This news propelled the stock price up by 42.76%. Source: SEC announcement

2. No other significant news recently. The market reacted positively to the acquisition plan, with noticeable capital inflow